Increase Protein Intake in Elderly

May 15, 2014 updated by: Wageningen University and Research
The objective of this study is to investigate the acceptance, intake, and compliance of protein enriched bread and protein enriched yoghurt drinks in elderly patients in two real life settings (short term; hospital, and longer term; rehabilitation home).

Study Overview

Status

Completed

Detailed Description

Prevalence rates of protein-energy malnutrition in elderly are high. In order to prevent loss of muscle mass and remain physically independent, it is utmost important for elderly to maintain their body protein mass. A sufficient protein supply according to their needs is therefore highly important. Especially for frail elderly, it is not easy to realize an increased protein intake by simply eating more. It is hypothesized that protein enriched food products that fit in a habitual diet (dairy and bread), result in a higher protein intake compared to regular products.

Study Type

Interventional

Enrollment (Actual)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amsterdam, Netherlands
        • VU University Medical Center
      • Groesbeek, Netherlands
        • Rehabilitation home "Herstelhotel Dekkerswald"

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • admitted to the department of internal medicine of VU university medical center or to the rehabilitation department of "Herstelhotel Dekkerswald"
  • signed informed consent
  • age of 55 or more
  • rehabilitating from a hospital stay with the aim to return back home (rehabilitation home only)
  • likely to remain admitted at least 3 weeks (rehabilitation home only).

Exclusion Criteria:

  • not speaking Dutch language
  • allergy for milk, soy or gluten
  • a medical condition that is considered by the treating physician as a contra indication for receiving protein enriched food products
  • a diet that does not allow the use of normal bread or dairy products (e.g. fluid diet, strong sodium restricted diet)
  • not able to eat or feed themselves
  • receiving tube feeding or parenteral nutrition
  • suffering from a terminal illness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Protein enriched yoghurt drink and bread
Yoghurt drink enriched with Whey Protein Concentrate Whole wheat bread enriched with cereal protein and soy
No Intervention: Regular yoghurt drink and bread
Commercially available yoghurt drink and whole wheat bread

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Protein intake measured on an individual level over 24h
Time Frame: 3 days (hospital), 3 weeks (rehabilitation home)
3 days (hospital), 3 weeks (rehabilitation home)

Secondary Outcome Measures

Outcome Measure
Time Frame
Intake of macronutrients (besides protein), total energy, calcium and fibre measured on an individual level over 24h.
Time Frame: 3 days (hospital), 3 weeks (rehabilitation home)
3 days (hospital), 3 weeks (rehabilitation home)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Product evaluation
Time Frame: 3 days (hospital), 3 weeks (rehabilitation home)
Questionnaire on appreciation and acceptance of protein enriched food products
3 days (hospital), 3 weeks (rehabilitation home)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Esther Boelsma, PhD, Wageningen UR Food and Biobased Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

July 22, 2013

First Submitted That Met QC Criteria

July 22, 2013

First Posted (Estimate)

July 24, 2013

Study Record Updates

Last Update Posted (Estimate)

May 16, 2014

Last Update Submitted That Met QC Criteria

May 15, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • NL43997.081.13
  • TKI-AF 12065 (Other Grant/Funding Number: Stichting Topconsortium voor Kennis en Innovatie Agri & Food)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Markedly Reduced Food Intake

Clinical Trials on Protein enriched yoghurt drink and bread

3
Subscribe